2025 ICD-10-CM code B40.1
(Active) Effective Date: N/A Certain infectious and parasitic diseases - Mycoses 1 Feed
Chronic pulmonary blastomycosis.
Medical necessity for treating chronic pulmonary blastomycosis is established by confirming the diagnosis through laboratory testing and imaging and demonstrating the clinical impact of the infection, such as respiratory compromise, systemic spread, or other related complications.
Clinicians diagnose chronic pulmonary blastomycosis based on patient history (including travel to endemic areas), physical examination, and symptoms. They conduct laboratory tests like blood and sputum analysis, lung biopsies, and bronchoscopy, and use imaging (chest X-ray and CT scans) to assess the extent of infection. Treatment involves prescribing antifungal medications like itraconazole or amphotericin B.
In simple words: Chronic pulmonary blastomycosis is a long-lasting lung infection caused by a fungus found in soil and decaying matter. People with weaker immune systems are more vulnerable. It can cause pneumonia-like symptoms and, if severe, breathing problems. The infection can also spread to other parts of the body. Doctors diagnose it using tests like bloodwork, sputum cultures, and imaging scans. Treatment usually involves antifungal medications.
Chronic pulmonary blastomycosis is a fungal infection of the lungs caused by inhaling air contaminated with the spores of the fungus Blastomyces dermatitidis. This fungus is typically found in moist soil and decaying organic matter in regions like the central and southeastern United States.It primarily affects individuals with weakened immune systems, beginning with pulmonary involvement and potentially progressing to chronic pneumonia. Symptoms may include fever, weight loss, excessive sweating, and a productive cough. In severe cases, it can manifest as acute respiratory distress syndrome (ARDS) with fever, difficulty breathing, hypoxia, and rapid breathing, which can be life-threatening. The infection can spread through the bloodstream to other parts of the body, affecting the skin, bones, joints, genitourinary system, and the central nervous system (CNS). Diagnosis involves considering the patient's travel history to endemic areas, physical examination, and symptoms. Laboratory tests such as blood and sputum tests for antibodies or cultures, lung biopsy for microscopic analysis and staining, and bronchoscopy for laboratory analysis of lung washings are used. Imaging techniques like chest X-rays and CT scans help assess the extent of lung involvement. Treatment usually consists of oral antifungal medications like itraconazole. For immunocompromised patients, those with severe disease, or CNS involvement, amphotericin B may be prescribed.
Example 1: A middle-aged individual with a history of immunosuppression presents with persistent cough, fever, night sweats, and weight loss. After a thorough examination, including laboratory tests and imaging, they are diagnosed with chronic pulmonary blastomycosis., An individual who recently traveled to an endemic area develops acute respiratory distress syndrome (ARDS) with rapid breathing and low oxygen levels. Further investigation reveals chronic pulmonary blastomycosis., An elderly patient with a weakened immune system exhibits skin lesions and joint pain in addition to respiratory symptoms. Diagnostic tests confirm chronic pulmonary blastomycosis with dissemination to the skin and joints.
Documentation should include: signs and symptoms, travel history to endemic areas, laboratory results (blood/sputum tests, cultures, biopsy), imaging findings (chest X-ray, CT scan), and treatment plan (antifungal medications).
- Specialties:Infectious Disease, Pulmonology
- Place of Service:Inpatient Hospital, Office